Endocrine Regulations (Jul 2022)
Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency
Abstract
Objective. The study was aimed to assess the effect of hydrocortisone (HC) replacement therapy on bone mineral density (BMD) and bone turnover markers in patients with primary adrenal insufficiency (PAI).
Keywords